Developer of pharmaceutical drugs. The company's pharmaceutical drugs development services enable businesses to engage in the full cycle of drug development -- from exploratory research, clinical development, manufacturing and marketing. Its pipeline includes drug therapies for prostate cancer, breast cancer, pediatric ependymoma, overactive bladder and rheumatoid arthritis. read more
David Naccarato — Executive Director, GBS Head of Transition and Transformation at Astellas Pharma
Executive Bio
David Naccarato serves as the Executive Director, GBS Head of Transition and Transformation of Astellas Pharma. David Naccarato and the Astellas Pharma executive team are rated a F by 7 employees.
Executive Team Culture Ratings from Astellas Pharma Employees
BOTTOM
5%
Astellas Pharma's Executive Team scores in the Bottom 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Astellas PharmaNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Astellas PharmaAstellas Pharma's Executive Team at a Glance
Based on 7 ratings, Astellas Pharma's employees are less satisfied with their Executive Team and give them a “F” or 46/100.
Astellas Pharma's Executive Team ranks in the Bottom 5% of other companies on Comparably that also have 10,000+ Employees.
×